8-K/A: Korro Bio Board Adopts Annual Say-on-Pay Vote Frequency Following Shareholder Approval

Korro Bio, Inc. announced that its Board of Directors has determined to hold annual non-binding advisory votes on executive compensation, aligning with the preference expressed by stockholders at the 2025 Annual Meeting.

Summary

• This Current Report on Form 8-K/A is an amendment to the original Form 8-K filed by Korro Bio, Inc. on June 11, 2025.
• The sole purpose of this amendment is to disclose the decision of Korro's Board of Directors regarding the frequency of future non-binding advisory votes on the compensation of its named executive officers.
• At the 2025 Annual Meeting of stockholders held on June 11, 2025, stockholders adopted a non-binding, advisory resolution approving the '1 Year' option for the frequency of future advisory votes on executive compensation.
• In light of these results, Korro's Board of Directors has determined that advisory votes on the compensation of its named executive officers will be held each year.
• The next non-binding advisory vote on the frequency of future advisory votes on executive compensation is required to occur no later than Korro's 2031 annual meeting of stockholders.

Sentiment

Score: 5

Explanation: The document reports a routine corporate governance update, reflecting a procedural decision based on shareholder voting, with no direct positive or negative financial implications.

Positives

• The company's Board of Directors is aligning its corporate governance practices with the expressed preference of its stockholders regarding the frequency of executive compensation votes, enhancing shareholder engagement and transparency.

Future Outlook

The company will hold annual non-binding advisory votes on executive compensation until at least its 2031 annual meeting, at which point another advisory vote on the frequency of such votes will be conducted.

Industry Context

The decision to hold annual advisory votes on executive compensation is a common practice among publicly traded companies in the U.S., reflecting a broader trend towards increased corporate governance and shareholder engagement, particularly following the Dodd-Frank Wall Street Reform and Consumer Protection Act's 'say-on-pay' provisions.

Comparison to Industry Standards

• Korro Bio's decision to adopt an annual frequency for advisory votes on executive compensation aligns with the prevailing practice among S&P 500 companies, where a significant majority (over 90%) hold 'say-on-pay' votes annually. This positions Korro Bio's governance practices in line with leading industry benchmarks for shareholder oversight of executive remuneration.

Corporate Governance

Stakeholder Impact

• Shareholders: Benefit from increased frequency of advisory votes on executive compensation, providing more regular opportunities to express their views on management's pay practices and enhancing corporate accountability.

Next Steps

• Korro Bio will hold annual non-binding advisory votes on the compensation of its named executive officers.
• The next non-binding advisory vote on the frequency of these votes will occur no later than Korro's 2031 annual meeting of stockholders.

Key Dates

Keywords

Korro Bio, executive compensation, say-on-pay, corporate governance, shareholder vote, 8-K/A, annual meeting